Dyskinesia, Drug-Induced (epidemiology) < Dyskinesia, Drug-Induced (etiology) < Dyskinesia, Drug-Induced (genetics)

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 45.
[0-20] [0 - 20][0 - 45][20-40]

Ident.	Authors (with country if any)	Title
000010 (1999)	F. Durif [France] ; M. Vidailhet ; B. Debilly ; Yves Agid [France]	Worsening of levodopa-induced dyskinesias by motor and mental tasks.
000061 (1999)	M. Vidailhet [France] ; A M Bonnet ; R. Marconi ; F. Durif ; Yves Agid [France]	The phenomenology of L-dopa-induced dyskinesias in Parkinson's disease.
000062 (1999)	O. Rascol [France]	L-dopa-induced peak-dose dyskinesias in patients with Parkinson's disease: a clinical pharmacologic approach.
000098 (2000)	P. Damier [France] ; L. Tremblay ; J. Féger ; E C Hirsch	[Development of dyskinesias induced by treatment for Parkinson's disease: potential role of first exposure to L-DOPA (or phenomenon of priming)].
000112 (2000)	B P Bejjani [France] ; I. Arnulf ; S. Demeret ; P. Damier ; A M Bonnet ; J L Houeto ; Yves Agid [France]	Levodopa-induced dyskinesias in Parkinson's disease: is sensitization reversible?
000116 (2000)	O. Rascol [France] ; D J Brooks ; A D Korczyn ; P P De Deyn ; C E Clarke ; A E Lang	A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa.
000158 (2000)	V. Fraix [France] ; P. Pollak ; N. Van Blercom ; J. Xie ; P. Krack ; A. Koudsie ; A L Benabid	Effect of subthalamic nucleus stimulation on levodopa-induced dyskinesia in Parkinson's disease.
000197 (2001)	F. Maurel [France] ; H. Lilliu ; C. Le Pen	[Social and economic cost of L-Dopa-induced dyskinesias in patients with Parkinson's disease].
000252 (2002)	P. Krystkowiak [France] ; L. Defebvre	[Rush dyskinesia scale or Goetz scale].
000316 (2003)	Olivier Rascol ; Pierre Payoux ; Fabienne Ory ; Joaquim J. Ferreira ; Christine Brefel-Courbon ; Jean-Louis Montastruc	Limitations of current Parkinson's disease therapy.
000323 (2002)	O. Rascol [France] ; J J Ferreira ; P. Payoux ; Ch Brefel-Courbon ; J L Montastruc	[Management of levodopa-induced dyskinesia].
000355 (2003)	Sylvie Raoul [France] ; Mirella Faighel ; Isabelle Rivier ; Marc Vérin ; Youenn Lajat ; Philippe Damier	Staged lesions through implanted deep brain stimulating electrodes: a new surgical procedure for treating tremor or dyskinesias.
000390 (2003)	Paul Krack [France] ; Alina Batir ; Nadège Van Blercom ; Stephan Chabardes ; Valérie Fraix ; Claire Ardouin ; Adnan Koudsie ; Patricia Dowsey Limousin ; Abdelhamid Benazzouz ; Jean François Lebas ; Alim-Louis Benabid ; Pierre Pollak	Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease.
000404 (2003)	Bechir Jarraya [France] ; Anne-Marie Bonnet ; Charles Duyckaerts ; Jean-Luc Houeto ; Philippe Cornu ; Jean-Jacques Hauw ; Yves Agid [France]	Parkinson's disease, subthalamic stimulation, and selection of candidates: a pathological study.
000418 (2004)	F. Durif [France] ; B. Debilly ; M. Galitzky ; D. Morand ; F. Viallet ; M. Borg ; S. Thobois ; E. Broussolle ; O. Rascol	Clozapine improves dyskinesias in Parkinson disease: a double-blind, placebo-controlled study.
000449 (????)	V. Mesnage [France] ; J L Houeto ; A M Bonnet ; I. Clavier ; I. Arnulf ; F. Cattelin ; G. Le Fur ; P. Damier ; M L Welter ; Yves Agid	Neurokinin B, neurotensin, and cannabinoid receptor antagonists and Parkinson disease.
000506 (????)	O. Rascol [France] ; D J Brooks ; E. Melamed ; W. Oertel ; Werner Poewe ; F. Stocchi ; E. Tolosa	Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial.
000521 (2005)	C. Guigoni [France] ; I. Aubert ; Q. Li ; V V Gurevich ; J L Benovic ; S. Ferry ; U. Mach ; H. Stark ; L. Leriche ; K. H Kansson ; Bernard H. Bioulac ; Christian E. Gross ; Pierre Sokoloff ; Gilberto Fisone ; E V Gurevich ; Bertrand Bloch ; Erwan Bezard	Pathogenesis of levodopa-induced dyskinesia: focus on D1 and D3 dopamine receptors.
000560 (2005)	Véronique Sgambato-Faure [France] ; Virginie Buggia ; François Gilbert ; Daniel Lévesque ; Alim-Louis Benabid ; François Berger	Coordinated and spatial upregulation of arc in striatonigral neurons correlates with L-dopa-induced behavioral sensitization in dyskinetic rats.
000642 (2006)	Olivier Rascol [France] ; David J. Brooks ; Amos D. Korczyn ; Peter P. De Deyn ; Carl E. Clarke ; Anthony E. Lang ; Mona Abdalla	Development of dyskinesias in a 5-year trial of ropinirole and L-dopa.
000918 (2008)	Agnès Nadjar [France] ; Charles R. Gerfen [États-Unis] ; Erwan Bezard [France]	Priming for L-dopa-induced dyskinesia in Parkinson’s disease: a feature inherent to the treatment or the disease?

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Dyskinesia, Drug-Induced (etiology)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Dyskinesia, Drug-Induced (etiology)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Dyskinesia, Drug-Induced (etiology)
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024